中国寄生虫学与寄生虫病杂志

• 学术争鸣 • 上一篇    下一篇

黑热病后皮肤利什曼病

管立人*, 高春花   

  1. 中国疾病预防控制中心寄生虫病预防控制所, 世界卫生组织热带病合作中心, 科技部国家级热带病国际联合研究中心, 卫生部寄生虫病原与媒介生物学重点实验室, 上海 200025
  • 出版日期:2017-08-30 发布日期:2017-09-14

Post kala-azar dermal leishmaniasis

GUAN Li-ren*, GAO Chun-hua   

  1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology; Key Laboratory of Parasite and Vector Biology, Ministry of Health, Shanghai 200025, China
  • Online:2017-08-30 Published:2017-09-14

摘要:

黑热病后皮肤利什曼病(post kala-azar dermal leishmaniasis, PKDL)在印度和苏丹等国家的内脏利什曼病(黑热病)流行区颇为常见, 并且是当地内脏利什曼病的主要传染源。PKDL在我国的发病人数虽然不多, 但近年来在西部的内脏利什曼病流行区仍有出现。由于PKDL患者的皮肤结节酷似瘤型麻风, 极易造成误诊误治。本文重点介绍了国内外对PKDL的临床表现、诊断、治疗以及发病机制等方面的研究进展, 同时也对PKDL和皮肤利什曼病的鉴别要点作了介绍。希望能对从事利什曼病和皮肤病的科研和防治人员有所裨益。

关键词: 黑热病后皮肤利什曼病, 杜氏利什曼原虫种团, 皮肤利什曼病, 硕大利什曼原虫, 热带利什曼原虫

Abstract:

Post kala-azar dermal leishmaniasis (PKDL) is rather common in endemic areas of visceral leishmaniasis (kala-azar) in India and Sudan, and is the main infectious source of local visceral leishmaniasis. Despite the low incidence of PKDL in China, it still occurs in kala-azar endemic areas in the western part of the country. The similarity between PKDL-induced skin nodules and the tumer-form leprosy is very likely to cause misdiagnosis and mistherapy of the two diseases. In this review, we focus on research progress on the clinical manifestation, diagnosis, treatment, and pathogenesis of PKDL, as well as proposing key points to distinguish between PKDL and cutaneous leishmaniasis, in the aim to help professionals engaged in research and control of leishmaniasis and skin diseases.

Key words: Post kala-azar dermal leishmaniasis, Leishamania donovani complex, Cutaneous leishmaniasis, Leishamania major, Leishamania tropica